Abstract
Purpose
Tissue redox state is an important mediator of various biological processes in health and diseases such as cancer. Previously, we discovered that the mitochondrial redox state of ex vivo tissues detected by redox scanning (an optical imaging method) revealed interesting tumor redox state heterogeneity that could differentiate tumor aggressiveness. Because the noninvasive chemical exchange saturation transfer (CEST) MRI can probe the proton transfer and generate contrasts from endogenous metabolites, we aim to investigate if the in vivo CEST contrast is sensitive to proton transfer of the redox reactions so as to reveal the tissue redox states in breast cancer animal models.
Procedures
CEST MRI has been employed to characterize tumor metabolic heterogeneity and correlated with the redox states measured by the redox scanning in two human breast cancer mouse xenograft models, MDA-MB-231 and MCF-7. The possible biological mechanism on the correlation between the two imaging modalities was further investigated by phantom studies where the reductants and the oxidants of the representative redox reactions were measured.
Results
The CEST contrast is found linearly correlated with NADH concentration and the NADH redox ratio with high statistical significance, where NADH is the reduced form of nicotinamide adenine dinucleotide. The phantom studies showed that the reductants of the redox reactions have more CEST contrast than the corresponding oxidants, indicating that higher CEST effect corresponds to the more reduced redox state.
Conclusions
This preliminary study suggests that CEST MRI, once calibrated, might provide a novel noninvasive imaging surrogate for the tissue redox state and a possible diagnostic biomarker for breast cancer in the clinic.
Similar content being viewed by others
References
Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res 38:2651–2660
Kumar R, Kuniyasu H, Bucana CD et al (1998) Spatial and temporal expression of angiogenic molecules during tumor growth and progression. Oncol Res 10:301–311
Eberhard A, Kahlert S, Goede V et al (2000) Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 60:1388–1393
Picchio M, Beck R, Haubner R et al (2008) Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography. J Nucl Med 49:597–605
Gonzalez-Garcia I, Sole RV, Costa J (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A 99:13085–13089
Schroeder T, Yuan H, Viglianti BL et al (2005) Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat. Cancer Res 65:5163–5171
Li LZ, Zhou R, Xu HN et al (2009) Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A 106:6608–6613
Xu HN, Zheng G, Tchou J et al (2013) Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging. SpringerPlus 2:73
Xu HN, Tchou J, Li LZ (2013) Redox imaging of human breast cancer core biopsies: a preliminary investigation. Acad Radiol 20:764–768
Xu HN, Nioka S, Glickson JD et al (2010) Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt 15:036010
Gerlinger M, Rowan AJ, Horswell S et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892
Fidler IJ (1987) Review: biologic heterogeneity of cancer metastases. Breast Cancer Res Treat 9:17–26
Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005) Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8:299–309
Ying WH (2008) NAD(+)/ NADH and NADP(+)/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10:179–206
Orrenius S, Gogvadze A, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol 47:143–183
Li LZ (2012) Imaging mitochondrial redox potential and its possible link to tumor metastatic potential. J Bioenerg Biomembr 44:645–653
Quistorff B, Haselgrove JC, Chance B (1985) High spatial-resolution readout of 3-D metabolic organ structure—an automated, low-temperature redox ratio-scanning instrument. Anal Biochem 148:389–400
Li LZ, Zhou R, Zhong T et al (2007) Predicting melanoma metastatic potential by optical and magnetic resonance imaging. Adv Exp Med Biol 599:67–78
Xu HN, Nioka S, Li LZ (2013) Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model. Biomark Res 1:6
Xu HN, Feng M, Moon L et al (2013) Redox imaging of the p53-dependent mitochondrial redox state in colon cancer ex vivo. J Innov Opt Health Sci 6(3):1350016
Ostrander JH, McMahon CM, Lem S et al (2010) Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Res 70:4759–4766
Walsh AJ, Cook RS, Manning HC et al (2013) Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. Cancer Res 73:6164–6174
Zhou JY, Tryggestad E, Wen ZB et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–U308
van Zijl PC, Jones CK, Ren J et al (2007) MRI detection of glycogen in vivo by using chemical exchange saturation transfer imaging (glycoCEST). Proc Natl Acad Sci U S A 104:4359–4364
Ling W, Regatte RR, Navon G, Jerschow A (2008) Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A 105:2266–2270
Haris M, Cai K, Singh A et al (2011) In vivo mapping of brain myo-inositol. Neuroimage 54:2079–2085
Cai K, Haris M, Singh A et al (2012) Magnetic resonance imaging of glutamate. Nat Med 18:302–306
Cai K, Xu HN, Singh A et al (2013) Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning. Adv Exp Med Biol 765:39–45
Cheng LL, Chang IW, Smith BL, Gonzalez RG (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135:194–202
Sitter B, Sonnewald U, Spraul M et al (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15:327–337
Veech RL (2006) The determination of the redox states and phosphorylation potential in living tissues and their relationship to metabolic control of disease phenotypes. Biochem Mol Biol Educ: Bimon Publ Int Union Biochem Mol Biol 34:168–179
Haris M, Nanga RP, Singh A et al (2012) Exchange rates of creatine kinase metabolites: feasibility of imaging creatine by chemical exchange saturation transfer MRI. NMR Biomed 25:1305–1309
Zhou J, Tryggestad E, Wen Z et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130–134
Ameri K, Luong R, Zhang H et al (2010) Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br J Cancer 102:561–569
Xu HN, Zhou R, Nioka S et al (2009) Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials. Adv Exp Med Biol 645:247–253
Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123:3678–3684
Kung H-N, Marks JR, Chi J-T (2011) Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genet 7:e1002229
Cuperlovic-Culf M, Chute IC, Culf AS et al (2011) 1H NMR metabolomics combined with gene expression analysis for the determination of major metabolic differences between subtypes of breast cell lines. Chem Sci 2:2263–2270
Li LZ, Xu HN, Ranji M et al (2009) Mitochondrial redox imaging for cancer diagnostic and therapeutic studies. J Innov Opt Health Sci 2:325–341
Lemasters JJ, Nieminen AL (2001) Mitochondria in pathogenesis. Kluwer Academic/Plenum Publishers.
Boschi F, Marzola P, Sandri M et al (2008) Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-albumin and B-22956/1 in an experimental model of mammary carcinoma. MAGMA 21:169–176
Horas JA, Olguin OR, Rizzotto MG (2005) On the surviving fraction in irradiated multicellular tumour spheroids: calculation of overall radiosensitivity parameters, influence of hypoxia and volume effects. Phys Med Biol 50:1689–1701
Cao Y, Nagesh V, Hamstra D et al (2006) The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 66:8912–8917
Liu G, Li Y, Sheth VR, Pagel MD (2012) Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging 11:47–57
Bhujwalla ZM, Artemov D, Ballesteros P et al (2002) Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed 15:114–119
Cai K, Shore A, Singh A et al (2012) Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research. NMR Biomed 25:1125–1132
Winter PM, Schmieder AH, Caruthers SD et al (2008) Minute dosages of alpha(nu)beta(3)-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits. FASEB J 22:2758–2767
Jackson A, O’Connor JPB, Parker GJM, Jayson GC (2007) Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13:3449–3459
Acknowledgments
The authors thank Drs. Steve Pickup and Weixia Liu for their technical assistance with animal MRI scanners. This work was supported by the National Center for Research Resources and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health through grant number P41 EB015893 and NIH grants R21-DA032256, R01-CA155348, and 2U24-CA083105. The work was also supported by a grant from Susan G. Komen Research Foundation (KG081069).
Conflict of Interest
The authors disclose no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, K., Xu, H.N., Singh, A. et al. Breast Cancer Redox Heterogeneity Detectable with Chemical Exchange Saturation Transfer (CEST) MRI. Mol Imaging Biol 16, 670–679 (2014). https://doi.org/10.1007/s11307-014-0739-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-014-0739-y